Seres Therapeutics CEO: Banking On Bacteria | Mad Money | CNBC

Seres Therapeutics CEO: Banking On Bacteria | Mad Money | CNBC


This biotech tripled in its June IPO, but it’s been a rollercoaster ever since. Is it time to buy? » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC » Watch more …


source


Comments

Popular posts from this blog

Alcohol, Aging, and Curing Cancer